Citation

Pinto JP, Morais SL, Hallak JEC, Dursun SM. Prim. Care Companion J. Clin. Psychiatry 2006; 8(6): 377-378.

Copyright

(Copyright © 2006, Physicians Postgraduate Press)

DOI

10.4088/pcc.v08n0611b

PMID

unavailable

Abstract

We report a case of olanzapine treatment of psychotic symptoms related to systemic lupus erythematosus (SLE). There is evidence that SLE can affect the central nervous system, among other parts of the body. Reports of psychotic presentation in SLE are rare, but such presentations are often dramatic, causing impairment in quality of life and difficulties for treatment.1,2 To our knowledge, there are no reports of effectiveness of olanzapine, an atypical antipsychotic, for SLE-related psychosis.

Language: en

Keywords

adolescent; human; female; case report; insomnia; psychosis; suicide attempt; treatment outcome; hospital admission; clinical feature; letter; disease course; haloperidol; treatment withdrawal; drug efficacy; olanzapine; extrapyramidal syndrome; anamnesis; systemic lupus erythematosus; agitation; dose response; azathioprine; methylprednisolone; auditory hallucination; drug dose reduction; persecutory delusion; drug dose increase; prednisolone; visual hallucination; hydroxychloroquine